Robert Lucas, director of quality compliance, regulatory and auditing at Verista, explores why life sciences leaders need to rethink compliance as an integrated, continuously managed discipline to keep pace with
Francisco Manuel Reyes Sosa, head of business development at 53Biologics, explores why biotech companies need flexible CDMOs for early-stage biologics.
For an early-stage biotech company, the route from
Ash Kamath, senior director – Americas, EMEA & CIS and Dipanjan Paul, marketing manager, ACG Inspection look at the benefits of AI-powered inspection.
Pharmaceutical manufacturing is undergoing a fundamental shift
Grace Gong, market manager checkweighing, Mettler Toledo, explores how intelligent checkweighers can improve productivity.
Consistency, accuracy, and speed sit at the heart of pharmaceutical production. Whether filling vials, running blister
Vijetha Bhat, cell and gene technical expert, Lonza Specialized Modalities, Ramesh Koukuntla, head of MSAT, Lonza Specialized Modalities and Laura Sands, regional head, Regulatory Affairs, US Region 2 looks at
Dr. Vincent Jannin, director of R&D and head of Innovaform Accelerator, Lonza Capsugel, discusses the next generation of capsule and coating technologies, from advancing oral biologics and targeted
Olivia Friett discusses the future of pharmaceutical manufacturing with Britton Jimenez, SVP, sales and marketing, Codexis at CPHI Milan.
As the pharmaceutical industry responds to growing demand for complex therapeutics,
Mike King, senior director of product & strategy, quality, regulatory, safety & detect at IQVIA, explores how the growing role of combination products and companion diagnostics in pharmaceutical portfolios is
Natalia Dadivanyan, market development manager - pharma small molecule at Malvern Panalytical, explains how manufacturers can keep production moving while maintaining tablet quality.
Following Andy Burnham's meeting with Arichie Goodburn and the announcement of a national brain cancer lead and accelerated MHRA reviews, chief scientific officer at CRISM Therapeutics Chris McConville gave his insight regarding the news.
Antoine Kabre, electrical & controls engineering manager at PSB Industries, shares how historical operating data can turn a shutdown alarm into a starting point for understanding equipment behaviour, identifying recurring problems.
Dan Williams PhD, CEO at SynaptixBio discusses current approaches to delivering drugs into the central nervous system (CNS), focusing on the specific challenges for key therapies like gene-silencing drugs that aim to treat rare neurological diseases.